Abstract
Neonates born to mothers with immune thrombocytopenia (ITP) have an increased risk for neonatal thrombocytopenia and hemorrhagic complications. The aim of this study was to determine the maternal and neonatal outcomes of pregnancies with ITP and also to identify risk factors that predicts neonatal thrombocytopenia. We performed a retrospective analysis of 40 pregnancies with ITP and their 40 neonates. Among the 40 neonates, thrombocytopenia (platelet count of less than 150 × 109/L) was detected in 15 neonates (37.5 %) whom 8 of them had severe thrombocytopenia (platelet count of less than 50 × 109/L). Ten of the 15 neonates with thrombocytopenia required treatment to increase the platelet counts. There was statistically significant association between neonatal thrombocytopenia and maternal splenectomy history and maternal duration of thrombocytopenia. There was no statistically significant correlation between maternal platelet count and neonatal platelet count. Clinicians should pay special attention in these neonates because of risk for development of neonatal thrombocytopenia. Maternal and neonatal outcomes in patients with idiopathic thrombocytopenic purpura is generally good.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Verdy E, Bessous V, Dreyfus M, Kaplan C, Tchernia G, Uzan S (1997) Longitudinal analysis of platelet count and volume in normal pregnancy. Thromb Haemost 77:806–807
Myers B (2012) Diagnosis and management of maternal thrombocytopenia in pregnancy. Br J Haematol 158:3–15
Fujimura K, Harada Y, Fujimoto T, Kuramoto A, Ikeda Y, Akatsuka J et al (2002) Nationwide study of idiopathic thrombocytopenic purpura in pregnant women and the clinical influence on neonates. Int J Hematol 75:426–433
Loustau V, Debouverie O, Poitrine FC, Baili L, Khellaf M, Touboul C et al (2014) Effect of pregnancy on the course of immune thrombocytopenia: a retrospective study of 118 pregnancies in 82 women. Br J Haematol 166:929–935
Van der Lugt NM, Van Kampen A, Walter FJ, Brand A, Lopriore E (2013) Outcome and management in neonatal thrombocytopenia due to maternal idiopathic thrombocytopenic purpura. Vox Sang 105:236–243
Ozkan H, Cetinkaya M, Köksal N, Ali R, Güneş AM, Baytan B et al (2010) Neonatal outcomes of pregnancy complicated by idiopathic thrombocytopenic purpura. J Perinatol 30:38–44
Subbaiah M, Kumar S, Roy KK, Sharma JB, Singh N (2014) Pregnancy outcome in patients with idiopathic thrombocytopenic purpura. Arch Gynecol Obstet 289:269–273
Nisaratanaporn S, Sukcharoen N (2006) Outcome of idiopathic thrombocytopenic purpura in pregnancy in King Chulalongkorn Memorial Hospital. J Med Assos Thai 89:70–75
Webert KE, Mittal R, Sigouin C, Heddle NM, Kelton JG (2003) A retrospective 11-year analysis of obstetric patients with idiopathic thrombocytopenic purpura. Blood 102:4306–4311
Bayhan T, Tavil B, Korkmaz A, Unal S, Hanalioglu D, Yigit S et al (2015) Neonates born to mothers with immune thrombocytopenic purpura: a single center experience of 20 years. Blood Coagul Fibrinolysis. doi:10.1097/MBC.0000000000000378
Roberts I, Stanworth S, Murray NA (2008) Thrombocytopenia in the neonate. Blood Rev 22:173–186
Valat AS, Caulier MT, Devos P, Rugeri L, Wibaut B, Vaast P et al (1998) Relationships between severe neonatal thrombocytopenia and maternal characteristics in pregnancies associated with autoimmune thrombocytopenia. Br J Haematol 103:397–401
Koyama S, Tomimatsu T, Kanagawa T, Kumasawa K, Tsutsui T, Kimura T (2012) Reliable predictors of neonatal immune thrombocytopenia in pregnant women with idiopathic thrombocytopenic purpura. Am J Hematol 87:15–21
Hachisuga K, Hidaka N, Fujita Y, Fukushima K, Kato K (2014) Can we predict neonatal thrombocytopenia in offspring of women with idiopathic thrombocytopenic purpura? Blood Res 49:259–264
Yamada H, Kato EH, Kishida T, Negishi H, Makinoda S, Fujimoto S (1998) Risk Factors for neonatal thrombocytopenia in pregnancy complicated by idiopathic thrombocytopenic purpura. Ann Hematol 76:211–214
Kawaguchi K, Matsubara K, Takafuta T, Shinzato I, Tanaka Y, Iwata A et al (2014) Factors predictive of neonatal thrombocytopenia in pregnant women with immune thrombocytopenia. Int J Hematol 99:570–576
Koyama S, Tomimatsu T, Sawada K, Kanagawa T, Isobe A, Taniguchi Y et al (2010) Prenatal diagnosis of fetal intracranial hemorrhage in pregnancy complicated by idiopathic thrombocytopenic purpura. Prenat Diagn 30:489–491
Gill KK, Kelton JG (2000) Management of idiopathic thrombocytopenic purpura in pregnancy. Semin Hematol 37:275–289
Payne SD, Resnik R, Moore TR (1997) Maternal characteristics and risk of severe neonatal thrombocytopenia and intracranial hemorrhage in pregnancies complicated by autoimmune thrombocytopenia. Am J Obstet Gynecol 177:149–155
Kutuk MS, Croisille L, Gorkem SB, Yılmaz E, Korkmaz L, Bierling P et al (2014) Fetal intracranial hemorrhage related to maternal autoimmune thrombocytopenic purpura. Childs Nerv Syst 30:2147–2150
Belkin A, Levy A, Sheiner E (2009) Perinatal outcomes and complications of pregnancy in women with immune thrombocytopenic purpura. J Matern Fetal Neonatal Med. 22:1081–1085
Provan D, Stasi R, Newland A, Blanchette VS, Bolton PM, Bussel JB et al (2010) International consensus report on the investigation and management of primary immune thrombocytopenia. Blood 115:168–186
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Melekoğlu, N.A., Bay, A., Aktekin, E.H. et al. Neonatal Outcomes of Pregnancy with Immune Thrombocytopenia. Indian J Hematol Blood Transfus 33, 211–215 (2017). https://doi.org/10.1007/s12288-016-0708-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12288-016-0708-5